Details for: H2AX
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 30.52rCSI 35.25%PRS 70.33
-
CSI 20.98rCSI 24.02%PRS 88.78
-
CSI 20.49rCSI 58.49%PRS 84.09
-
CSI 20.22rCSI 24.28%PRS 75.58
-
CSI 19.06rCSI 15.79%PRS 80.44
-
CSI 18.52rCSI 25.73%PRS 76.67
-
CSI 17.3rCSI 17.71%PRS 86.21
-
CSI 17.16rCSI 14.22%PRS 78.48
-
CSI 15.94rCSI 16.24%PRS 87.79
-
CSI 13.46rCSI 10.59%PRS 83.36
-
CSI 10.51rCSI 21.8%PRS 74.62
-
CSI 10.04rCSI 17.19%PRS 84.37
-
CSI 9.13rCSI 8.25%PRS 76.15
-
CSI 8.79rCSI 6.31%PRS 90.16
-
CSI 8.17rCSI 12.62%PRS 76.97
-
CSI 8.12rCSI 10.34%PRS 82.89
-
CSI 7.7rCSI 24.99%PRS 75.86
-
CSI 7.34rCSI 5.52%PRS 83.67
-
CSI 7.12rCSI 10.16%PRS 78.8
-
CSI 7.03rCSI 5.89%PRS 80.97
-
CSI 6.51rCSI 10.4%PRS 81.59
-
CSI 6.5rCSI 7.85%PRS 85.65
-
CSI 6.42rCSI 16.25%PRS 83.26
-
CSI 6.36rCSI 34.32%PRS 84.84
-
CSI 6.22rCSI 13.9%PRS 85.01
-
CSI 5.92rCSI 4.12%PRS 91.32
-
CSI 5.62rCSI 8.97%PRS 69.67
-
CSI 5.54rCSI 4.48%PRS 80.28
-
CSI 5.36rCSI 7.42%PRS 75.38
-
CSI 5.33rCSI 7.26%PRS 94.05
-
CSI 5.28rCSI 4.62%PRS 85.34
-
CSI 5.07rCSI 4.45%PRS 83.04
-
CSI 4.73rCSI 4.38%PRS 91.95
-
CSI 4.67rCSI 6.25%PRS 76.8
-
CSI 4.44rCSI 5.58%PRS 86.8
-
CSI 4.41rCSI 3.82%PRS 82.11
-
CSI 4.27rCSI 4.11%PRS 77.22
-
CSI 4.14rCSI 11.9%PRS 73.85
-
CSI 4.05rCSI 17.78%PRS 86.65
-
CSI 3.7rCSI 3.25%PRS 66.85
-
CSI 3.59rCSI 2.92%PRS 77.25
-
CSI 3.59rCSI 2.72%PRS 89.69
-
CSI 3.42rCSI 2.71%PRS 66.35
-
CSI 3.32rCSI 2.58%PRS 91.5
-
CSI 3.27rCSI 3.04%PRS 78.42
-
CSI 3.24rCSI 3.4%PRS 75.26
-
CSI 3.19rCSI 2.22%PRS 88.91
-
CSI 3.19rCSI 21.89%PRS 84.92
-
CSI 3.18rCSI 2.83%PRS 75.68
-
CSI 3.14rCSI 3.88%PRS 75.75
-
CSI 3.11rCSI 2.17%PRS 81.26
-
CSI 3.09rCSI 7.02%PRS 78.8
-
CSI 3.05rCSI 4.46%PRS 82.75
-
CSI 3.04rCSI 2.98%PRS 91.12
-
CSI 3rCSI 2.76%PRS 79.39
-
CSI 2.85rCSI 2.84%PRS 71.65
-
CSI 2.85rCSI 8.49%PRS 88.1
-
CSI 2.78rCSI 4.01%PRS 84.16
-
CSI 2.71rCSI 17.44%PRS 87.9
-
CSI 2.71rCSI 5.36%PRS 87.06
-
CSI 2.61rCSI 4.01%PRS 86.36
-
CSI 2.6rCSI 2.24%PRS 79.13
-
CSI 2.58rCSI 6.56%PRS 71.25
-
CSI 2.58rCSI 3.52%PRS 69.4
-
CSI 2.46rCSI 1.83%PRS 88.58
-
CSI 2.41rCSI 6.91%PRS 93.54
-
CSI 2.39rCSI 3.27%PRS 82.36
-
CSI 2.33rCSI 2.63%PRS 90.57
-
CSI 2.29rCSI 3.49%PRS 85.34
-
CSI 2.28rCSI 1.81%PRS 93.75
-
CSI 2.27rCSI 1.76%PRS 81.43
-
CSI 2.22rCSI 2.38%PRS 79.06
-
CSI 2.12rCSI 3.24%PRS 81.9
-
CSI 2.12rCSI 3.67%PRS 69.25
-
CSI 2.09rCSI 2.01%PRS 91.77
-
CSI 2.06rCSI 3.9%PRS 88.99
-
CSI 2.03rCSI 4.2%PRS 75.53
-
CSI 2.03rCSI 2.6%PRS 81.32
-
CSI 2rCSI 2.07%PRS 82.26
-
CSI 1.9rCSI 2.38%PRS 87.12
-
CSI 1.88rCSI 5.28%PRS 72.93
-
CSI 1.88rCSI 6.67%PRS 95.52
-
CSI 1.87rCSI 2.16%PRS 69.92
-
CSI 1.85rCSI 4.91%PRS 84.24
-
CSI 1.81rCSI 1.9%PRS 75.55
-
CSI 1.72rCSI 3.11%PRS 92.89
-
CSI 1.7rCSI 2.45%PRS 85.13
-
CSI 1.66rCSI 3.54%PRS 84.61
-
CSI 1.61rCSI 7.1%PRS 66.45
-
CSI 1.53rCSI 1.33%PRS 87.36
-
CSI 1.5rCSI 6.48%PRS 85.5
-
CSI 1.48rCSI 3.45%PRS 84.43
-
CSI 1.43rCSI 3.26%PRS 71.93
-
CSI 1.32rCSI 1.57%PRS 92.3
-
CSI 1.21rCSI 3.33%PRS 84.89
-
CSI 1.18rCSI 12.83%PRS 86.58
-
CSI 1.18rCSI 6.27%PRS 94.84
-
CSI 1.16rCSI 5.82%PRS 89.25
-
CSI 1.15rCSI 4.97%PRS 83.88
-
CSI 1.14rCSI 2.19%PRS 94.29
-
CSI 0.2rCSI 1.1%PRS 82.3%
-
CSI 0.2rCSI 2.3%PRS 83.7%
-
CSI 0.2rCSI 4.3%PRS 94.2%
-
CSI 0.3rCSI 3.3%PRS 92.9%
-
CSI 0.3rCSI 1.6%PRS 94.6%
-
CSI 0.3rCSI 2.7%PRS 71.8%
-
CSI 0.4rCSI 6.7%PRS 86.2%
-
CSI 0.4rCSI 2.1%PRS 86.8%
-
CSI 0.5rCSI 2.6%PRS 83.8%
-
CSI 0.6rCSI 5.5%PRS 94.5%
-
CSI 0.7rCSI 2.5%PRS 82.5%
-
CSI 0.7rCSI 3.3%PRS 93.9%
-
CSI 0.8rCSI 2.6%PRS 80.2%
-
CSI 0.8rCSI 1.0%PRS 59.2%
-
CSI 1.0rCSI 12.8%PRS 94.1%
-
CSI 1.0rCSI 3.4%PRS 76.4%
-
CSI 1.0rCSI 2.4%PRS 83.8%
-
CSI 1.0rCSI 3.8%PRS 92.6%
-
CSI 1.1rCSI 2.6%PRS 91.9%
-
CSI 1.1rCSI 3.2%PRS 77.5%
-
CSI 1.1rCSI 1.8%PRS 67.9%
-
CSI 1.1rCSI 4.0%PRS 86.3%
-
CSI 1.1rCSI 2.2%PRS 94.3%
-
CSI 1.2rCSI 5.0%PRS 83.9%
-
CSI 1.2rCSI 5.8%PRS 89.3%
-
CSI 1.2rCSI 6.3%PRS 94.8%
-
CSI 1.2rCSI 12.8%PRS 86.6%
-
CSI 1.2rCSI 3.3%PRS 84.9%
-
CSI 1.3rCSI 1.6%PRS 92.3%
-
CSI 1.4rCSI 3.3%PRS 71.9%
-
CSI 1.5rCSI 3.5%PRS 84.4%
-
CSI 1.5rCSI 6.5%PRS 85.5%
-
CSI 1.5rCSI 1.3%PRS 87.4%
-
CSI 1.6rCSI 7.1%PRS 66.5%
-
CSI 1.7rCSI 3.5%PRS 84.6%
-
CSI 1.7rCSI 2.5%PRS 85.1%
-
CSI 1.7rCSI 3.1%PRS 92.9%
-
CSI 1.8rCSI 1.9%PRS 75.6%
-
CSI 1.9rCSI 4.9%PRS 84.2%
-
CSI 1.9rCSI 2.2%PRS 69.9%
-
CSI 1.9rCSI 6.7%PRS 95.5%
-
CSI 1.9rCSI 5.3%PRS 72.9%
-
CSI 1.9rCSI 2.4%PRS 87.1%
-
CSI 2.0rCSI 2.1%PRS 82.3%
-
CSI 2.0rCSI 2.6%PRS 81.3%
-
CSI 2.0rCSI 4.2%PRS 75.5%
-
CSI 2.1rCSI 3.9%PRS 89.0%
-
CSI 2.1rCSI 2.0%PRS 91.8%
-
CSI 2.1rCSI 3.7%PRS 69.3%
-
CSI 2.1rCSI 3.2%PRS 81.9%
-
CSI 2.2rCSI 2.4%PRS 79.1%
-
CSI 2.3rCSI 1.8%PRS 81.4%
-
CSI 2.3rCSI 1.8%PRS 93.8%
-
CSI 2.3rCSI 3.5%PRS 85.3%
-
CSI 2.3rCSI 2.6%PRS 90.6%
-
CSI 2.4rCSI 3.3%PRS 82.4%
-
CSI 2.4rCSI 6.9%PRS 93.5%
-
CSI 2.5rCSI 1.8%PRS 88.6%
-
CSI 2.6rCSI 3.5%PRS 69.4%
-
CSI 2.6rCSI 6.6%PRS 71.3%
-
CSI 2.6rCSI 2.2%PRS 79.1%
-
CSI 2.6rCSI 4.0%PRS 86.4%
-
CSI 2.7rCSI 5.4%PRS 87.1%
-
CSI 2.7rCSI 17.4%PRS 87.9%
-
CSI 2.8rCSI 4.0%PRS 84.2%
-
CSI 2.9rCSI 8.5%PRS 88.1%
-
CSI 2.9rCSI 2.8%PRS 71.7%
-
CSI 3.0rCSI 2.8%PRS 79.4%
-
CSI 3.0rCSI 3.0%PRS 91.1%
-
CSI 3.1rCSI 4.5%PRS 82.8%
-
CSI 3.1rCSI 7.0%PRS 78.8%
-
CSI 3.1rCSI 2.2%PRS 81.3%
-
CSI 3.1rCSI 3.9%PRS 75.8%
-
CSI 3.2rCSI 2.8%PRS 75.7%
-
CSI 3.2rCSI 21.9%PRS 84.9%
-
CSI 3.2rCSI 2.2%PRS 88.9%
-
CSI 3.2rCSI 3.4%PRS 75.3%
-
CSI 3.3rCSI 3.0%PRS 78.4%
-
CSI 3.3rCSI 2.6%PRS 91.5%
-
CSI 3.4rCSI 2.7%PRS 66.4%
-
CSI 3.6rCSI 2.7%PRS 89.7%
-
CSI 3.6rCSI 2.9%PRS 77.3%
-
CSI 3.7rCSI 3.3%PRS 66.9%
-
CSI 4.1rCSI 17.8%PRS 86.7%
-
CSI 4.1rCSI 11.9%PRS 73.9%
-
CSI 4.3rCSI 4.1%PRS 77.2%
-
CSI 4.4rCSI 3.8%PRS 82.1%
-
CSI 4.4rCSI 5.6%PRS 86.8%
-
CSI 4.7rCSI 6.3%PRS 76.8%
-
CSI 4.7rCSI 4.4%PRS 92.0%
-
CSI 5.1rCSI 4.5%PRS 83.0%
-
CSI 5.3rCSI 4.6%PRS 85.3%
-
CSI 5.3rCSI 7.3%PRS 94.1%
-
CSI 5.4rCSI 7.4%PRS 75.4%
-
CSI 5.5rCSI 4.5%PRS 80.3%
-
CSI 5.6rCSI 9.0%PRS 69.7%
-
CSI 5.9rCSI 4.1%PRS 91.3%
-
CSI 6.2rCSI 13.9%PRS 85.0%
-
CSI 6.4rCSI 34.3%PRS 84.8%
-
CSI 6.4rCSI 16.3%PRS 83.3%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 576387282
Symbol: H2AX_HUMAN
Name: Histone H2AX
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 2587254
Title: H2A.X. a histone isoprotein with a conserved C-terminal sequence, is encoded by a novel mRNA with both DNA replication type and polyA 3' processing signals.
PubMed ID: 2587254
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 9488723
Title: DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139.
PubMed ID: 9488723
PubMed ID: 10477747
Title: Megabase chromatin domains involved in DNA double-strand breaks in vivo.
PubMed ID: 10477747
PubMed ID: 10959836
Title: A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.
PubMed ID: 10959836
PubMed ID: 10734083
Title: Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139.
PubMed ID: 10734083
PubMed ID: 11673449
Title: Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress.
PubMed ID: 11673449
PubMed ID: 12419185
Title: NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.
PubMed ID: 12419185
PubMed ID: 12697768
Title: Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX.
PubMed ID: 12697768
PubMed ID: 12660252
Title: Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.
PubMed ID: 12660252
PubMed ID: 12607005
Title: MDC1 is a mediator of the mammalian DNA damage checkpoint.
PubMed ID: 12607005
DOI: 10.1038/nature01446
PubMed ID: 14627815
Title: DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner.
PubMed ID: 14627815
DOI: 10.1093/nar/gkg921
PubMed ID: 15059890
Title: ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation.
PubMed ID: 15059890
PubMed ID: 15201865
Title: Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention.
PubMed ID: 15201865
PubMed ID: 15489221
Title: Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species.
PubMed ID: 15489221
PubMed ID: 15613478
Title: Actinomycin D induces histone gamma-H2AX foci and complex formation of gamma-H2AX with Ku70 and nuclear DNA helicase II.
PubMed ID: 15613478
PubMed ID: 16310392
Title: gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair.
PubMed ID: 16310392
PubMed ID: 16820410
Title: Novel function of beta-arrestin2 in the nucleus of mature spermatozoa.
PubMed ID: 16820410
DOI: 10.1242/jcs.03046
PubMed ID: 18001824
Title: RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins.
PubMed ID: 18001824
PubMed ID: 18001825
Title: RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.
PubMed ID: 18001825
PubMed ID: 17709392
Title: DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics.
PubMed ID: 17709392
DOI: 10.1128/mcb.00579-07
PubMed ID: 17525332
Title: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
PubMed ID: 17525332
PubMed ID: 19203578
Title: The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage.
PubMed ID: 19203578
PubMed ID: 19203579
Title: RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins.
PubMed ID: 19203579
PubMed ID: 19092802
Title: WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity.
PubMed ID: 19092802
DOI: 10.1038/nature07668
PubMed ID: 19234442
Title: Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions.
PubMed ID: 19234442
DOI: 10.1038/nature07849
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 22980979
Title: RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.
PubMed ID: 22980979
PubMed ID: 24429368
Title: Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.
PubMed ID: 24429368
DOI: 10.1128/jvi.03568-13
PubMed ID: 25218447
Title: Uncovering global SUMOylation signaling networks in a site-specific manner.
PubMed ID: 25218447
DOI: 10.1038/nsmb.2890
PubMed ID: 26438602
Title: Acetylation of histone H2AX at Lys 5 by the TIP60 histone acetyltransferase complex is essential for the dynamic binding of NBS1 to damaged chromatin.
PubMed ID: 26438602
DOI: 10.1128/mcb.00757-15
PubMed ID: 26734725
Title: The proximity ligation assay reveals that at DNA double-strand breaks WRAP53beta associates with gammaH2AX and controls interactions between RNF8 and MDC1.
PubMed ID: 26734725
PubMed ID: 26721387
Title: Hepatoma-derived growth factor-related protein 2 promotes DNA repair by homologous recombination.
PubMed ID: 26721387
DOI: 10.1093/nar/gkv1526
PubMed ID: 28112733
Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
PubMed ID: 28112733
DOI: 10.1038/nsmb.3366
PubMed ID: 27715493
Title: Phosphorylation of the Cajal body protein WRAP53beta by ATM promotes its involvement in the DNA damage response.
PubMed ID: 27715493
PubMed ID: 31527692
Title: VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes.
PubMed ID: 31527692
PubMed ID: 35849344
Title: LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms.
PubMed ID: 35849344
DOI: 10.1093/nar/gkac611
PubMed ID: 22154951
Title: Specific recognition of phosphorylated tail of H2AX by the tandem BRCT domains of MCPH1 revealed by complex structure.
PubMed ID: 22154951
Sequence Information:
- Length: 143
- Mass: 15145
- Checksum: D4683775C2E6C3A9
- Sequence:
MSGRGKTGGK ARAKAKSRSS RAGLQFPVGR VHRLLRKGHY AERVGAGAPV YLAAVLEYLT AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGG VTIAQGGVLP NIQAVLLPKK TSATVGPKAP SGGKKATQAS QEY